Bilva (Aegle marmelos)

Bilva (Aegle marmelos) contains marmelosin, a compound demonstrating potent antioxidant activity with an IC₅₀ of 15.4 μM in laboratory studies. The herb works through antioxidant and anti-inflammatory pathways to combat oxidative stress and support immune function.

Origin & History

Aegle marmelos (L.) Correa, commonly known as Bael or Bilva, is a tree native to the Indian subcontinent that has been widely cultivated throughout South Asia. The fruit pulp is the primary source of bioactive compounds, extracted using methanol and water as optimal solvents, followed by ethanol.

Historical & Cultural Context

Aegle marmelos holds significant importance in Ayurvedic and traditional Indian medicine systems, where it has been valued for centuries. The fruit pulp has been traditionally employed for antidiarrheal purposes and digestive support, while leaves and bark have been used for various inflammatory and infectious conditions.

Health Benefits

• Antioxidant support - Marmelosin demonstrated potent antioxidant properties with IC₅₀ of ~15.4 ± 0.32 μM (in vitro evidence only)
• Anti-inflammatory effects - Strong antioxidant and anti-inflammatory activities shown to combat oxidative stress (mechanism studies, no clinical trials)
• Antimicrobial properties - Multiple compounds including citral, eugenol, and p-cymene exhibit antibacterial, antifungal, and antiparasitic properties (in vitro data)
• Potential anticancer activity - Methanol extract showed IC₅₀ of 47.08 μg/ml against HEp-2 cancer cells (cell line studies only)
• Traditional digestive support - Historically used for gastrointestinal conditions and antidiarrheal purposes (traditional use, no clinical validation)

How It Works

Bilva's primary bioactive compound marmelosin exhibits antioxidant activity by scavenging free radicals and reducing oxidative stress markers. The herb's anti-inflammatory effects appear to work through inhibition of pro-inflammatory pathways, though specific molecular targets require further investigation. Additional compounds in bilva may contribute to antimicrobial activity through disruption of bacterial cell membranes.

Scientific Research

The research indicates that clinical evidence remains limited, with sources specifically noting 'insufficient clinical trials to validate its safety and efficacy' and 'limited high-quality clinical trials.' No PubMed PMIDs or human clinical trial data were available in the research dossier.

Clinical Summary

Current evidence for bilva consists primarily of in vitro and animal studies, with limited human clinical trials available. Laboratory studies have quantified marmelosin's antioxidant potency at IC₅₀ values around 15.4 μM, demonstrating significant free radical scavenging activity. Animal studies suggest anti-inflammatory and antimicrobial properties, but human studies with specific dosages and clinical outcomes are lacking. The evidence base remains preliminary and requires well-designed human trials to establish therapeutic efficacy.

Nutritional Profile

Bilva (Aegle marmelos) fruit pulp contains approximately 61.5g carbohydrates, 1.8g protein, 0.3g fat, and 2.9g crude fiber per 100g dry weight. Moisture content in ripe fruit ranges 54-61%. Key micronutrients include calcium (85mg/100g), phosphorus (50mg/100g), iron (0.6mg/100g), potassium (600mg/100g), and vitamin C (8-60mg/100g depending on ripeness, with ripe fruit containing lower concentrations). Riboflavin (0.02mg/100g) and thiamine (0.13mg/100g) are present in modest amounts. Primary bioactive compounds include: marmelosin (imperatorin) at approximately 0.5-1.2% in fruit pulp, marmelide, and psoralen (furanocoumarins); alkaloids including aegeline (~0.01-0.02% in leaves) and O-methylhafforine; flavonoids including rutin and quercetin derivatives (total flavonoid content ~15-25mg QE/g in leaf extracts); tannins (4-9% in unripe fruit, significantly reduced in ripe fruit affecting astringency); pectin (approximately 5.5g/100g in ripe pulp, contributing to gel-forming capacity); essential oil components in leaves including citral (major volatile), eugenol, p-cymene, and limonene collectively comprising 60-70% of leaf volatile fraction; and beta-sitosterol and lupeol in root bark. Bioavailability note: furanocoumarin compounds like marmelosin are lipophilic and may benefit from co-consumption with dietary fat; tannin content in unripe fruit may inhibit iron and protein absorption; pectin content may modestly slow glucose absorption, supporting traditional use in digestive regulation.

Preparation & Dosage

No clinically studied dosage ranges for human use or standardized extract specifications are available from the research. The sources note that variability in phytochemical composition and lack of standardized formulations represent significant challenges to clinical application. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Amla, Ashwagandha, Triphala

Safety & Interactions

Bilva appears generally well-tolerated based on traditional use, but comprehensive safety data from clinical trials is limited. Potential interactions with diabetes medications may occur due to possible blood sugar effects observed in animal studies. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use due to immune-modulating properties.